Back

Spherix establishes Respiratory Franchise after two years of research

Verifying
  • Spherix Global Insights established a dedicated Respiratory Franchise spanning asthma, COPD and ILD research.
  • More than 15 consecutive months of monthly research support the respiratory program across the U.S. and Europe.
  • The 2026 portfolio includes asthma and COPD reports plus an ILD-in-rheumatology study.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Spherix establishes Respiratory Franchise after two years of research - CoinPost Terminal